» Articles » PMID: 1353144

Psychological and Social Consequences of Community Carrier Screening Programme for Cystic Fibrosis

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 1992 Jul 25
PMID 1353144
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

We have assessed the effect of screening for cystic fibrosis (CF) carrier status on anxiety levels, attitudes, knowledge and actions of participants in a pilot programme conducted through primary health care services. Over 3000 individuals were screened and 100 carriers with no previous family history were identified. Varying degrees of anxiety were found to be associated initially with a positive result, but most of this was allayed by genetic counselling, and we find no adverse long-term psychological consequences in carriers. Most discussed carrier status with their partner (89%), parents, other relatives and also with friends; 87% of partners to whom testing was suggested have been screened. Those testing positive indicated that knowledge of carrier status would be considered in future reproductive decisions, and after 6 months carriers retained a reasonable level of knowledge about CF and its inheritance. Carriers and non-carriers uniformly approve of screening and are glad to have been tested. Knowledge of CF in the sample of non-carriers has also increased after testing, suggesting screening may improve understanding of CF among the entire target population. Fears of possible social costs of screening may be ill-founded.

Citing Articles

Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Hussein N, Henneman L, Kai J, Qureshi N Cochrane Database Syst Rev. 2021; 10:CD010849.

PMID: 34634131 PMC: 8504980. DOI: 10.1002/14651858.CD010849.pub4.


Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Hussein N, Weng S, Kai J, Kleijnen J, Qureshi N Cochrane Database Syst Rev. 2018; 3:CD010849.

PMID: 29537064 PMC: 6494256. DOI: 10.1002/14651858.CD010849.pub3.


Exploring approaches to facilitate family communication of genetic risk information after cystic fibrosis population carrier screening.

Gorrie A, Archibald A, Ioannou L, Curnow L, McClaren B J Community Genet. 2017; 9(1):71-80.

PMID: 28971321 PMC: 5752656. DOI: 10.1007/s12687-017-0337-1.


Preconception risk assessment for thalassaemia, sickle cell disease, cystic fibrosis and Tay-Sachs disease.

Hussein N, Weng S, Kai J, Kleijnen J, Qureshi N Cochrane Database Syst Rev. 2015; (8):CD010849.

PMID: 26264938 PMC: 6486309. DOI: 10.1002/14651858.CD010849.pub2.


"Suddenly Having two Positive People who are Carriers is a Whole New Thing" - Experiences of Couples Both Identified as Carriers of Cystic Fibrosis Through a Population-Based Carrier Screening Program in Australia.

Ioannou L, Delatycki M, Massie J, Hodgson J, Lewis S J Genet Couns. 2015; 24(6):987-1000.

PMID: 25925605 DOI: 10.1007/s10897-015-9833-9.